Since NF is known to inhibit the RAS signaling pathway by promoting the conversion of RAS–GTP to RAS–GDP [13], we examined the phosphorylation status of the downstream signaling molecules, RAF and ERK, in BC cells following NF modulation. The gene discussed is NFASC; the disease is breast cancer.